Form D · Biotechnology
Braasch Biotech LLC
Garretson, SD · CIK 0001546815
Offering snapshot reported Apr 9, 2012 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 9, 2012 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Pooled investment fund
- Exemptions
- 05, 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-176345
Source: Form D, filed Apr 9, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeralyn Kay Haffer | Director, Executive |
| Keith Neil Haffer | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
421 Rose Ave
Garretson, SD, 57030
Garretson, SD, 57030